Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI

OBJECTIVE: To explore the effect of dapagliflozin on cardiac function, inflammation, and cardiovascular outcome in patients with ST-segment elevation myocardial infarction (STEMI) combined with type 2 diabetes (T2DM) after percutaneous coronary intervention (PCI). METHODS: 70 patients with STEMI and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, LiMing, Yuan, Xian, Zhang, Shuguang, Zhao, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536432/
https://www.ncbi.nlm.nih.gov/pubmed/34691230
http://dx.doi.org/10.1155/2021/9388562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536432/
https://www.ncbi.nlm.nih.gov/pubmed/34691230
http://dx.doi.org/10.1155/2021/9388562

Ejemplares similares